Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for...

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Mitochondrial dysfunction is a critical factor in neurodegenerative diseases like Parkinson's disease (PD).
• Key Parkinson's proteins (α-synuclein, Parkin, PINK1, DJ-1, LRRK2) are implicated in mitochondrial dysfunction and oxidative stress.
• Alpha-synuclein (α-Syn) may centrally mediate mitochondrial issues and oxidative stress via signaling pathways.

Purpose of the Study:

• To review the link between alpha-synuclein (α-Syn) and tau pathology with mitochondrial dysfunction in PD.
• To summarize mechanisms of α-Syn aggregation and phosphorylated tau targeting mitochondria.
• To identify novel therapeutic strategies for preventing PD progression.

Main Methods:

• Literature review of studies on PD pathogenesis.
• Analysis of the interplay between α-Syn, tau, and mitochondria.
• Examination of signaling pathways involved in protein aggregation and mitochondrial targeting.

Main Results:

• α-Syn aggregation and tau pathology exacerbate mitochondrial dysfunction and oxidative stress in PD.
• Interactions between α-Syn and tau amplify neurotoxic effects on mitochondria.
• Oxidative stress promotes the assembly of α-Syn and tau, contributing to aggregate formation.

Conclusions:

• The complex interplay between α-Syn, tau, and mitochondrial dysfunction is central to PD pathogenesis.
• Targeting these interactions offers promising avenues for developing PD therapeutics.
• Further research into these mechanisms could lead to effective PD prevention strategies.